Page last updated: 2024-09-03

1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine and Melanoma

1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine has been researched along with Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sahu, RP1
Ferracini, M; Sahu, RP; Travers, JB1

Other Studies

2 other study(ies) available for 1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine and Melanoma

ArticleYear
Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.
    Molecular medicine reports, 2015, Volume: 12, Issue:1

    Topics: Animals; Apoptosis; Azepines; Cell Line; Cell Proliferation; Gene Expression Regulation; Humans; Isothiocyanates; Melanoma; Mice; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Signal Transduction; Triazoles

2015
Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.
    Mediators of inflammation, 2015, Volume: 2015

    Topics: Animals; Antineoplastic Agents; Antioxidants; Etoposide; Female; Immunosuppression Therapy; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction

2015